Furthermore,better diagnostic accuracy will limit vasoconstrictor exposure and excessive andpotentially deleterious albumin dosing in those unlikely to respond to improvedrenal perfusion, such as patients with ATN. This evidence concerns the gene ALB and oculocutaneous albinism type 1.